Our singular focus on healthcare lets us deliver strategic and financial advice on our clients' most important decisions.
Filter
Mergers, Acquisitions & Strategic Advisory
MTS served as exclusive financial advisor to CleanSlate on its sale to Spero Health
Mergers, Acquisitions & Strategic Advisory
Zymeworks Inc. enters into a definitive agreement to acquire Theravance Biopharma, Inc. for $929mm
Mergers, Acquisitions & Strategic Advisory
MTS served as exclusive financial advisor to Knox Lane on its acquisition of Cross Country Healthcare (Nasdaq:CCRN)
Mergers, Acquisitions & Strategic Advisory
MTS served as lead financial advisor to Golden State Medical Supply, a portfolio company of Court Square, on its sale to Revelar Capital
Mergers, Acquisitions & Strategic Advisory
MTS served as financial advisor to Galapagos’ Independent Board of Directors on its collaboration agreement with Gilead Sciences for Ouro Medicines’ assets
Mergers, Acquisitions & Strategic Advisory
MTS served as exclusive financial advisor to CirrusMD on its sale to Quantum Health
Mergers, Acquisitions & Strategic Advisory
MTS served as exclusive financial advisor to Alma on its sale to Spring Health
Mergers, Acquisitions & Strategic Advisory
MTS served as exclusive financial advisor to DispatchHealth in the sale of its Mobile Imaging business to TridentCare
Mergers, Acquisitions & Strategic Advisory
MTS served as exclusive financial advisor to Neurocrine Biosciences, on its divestment of its European commercial business (Neurocrine Group Limited) to Immedica Pharma
